All Online

1 - 12 of 24 results

Refine

Active filters

Endocrinology
Senior female smiling, happily while lifting up small weight
1 CME CREDIT

Learn the latest on the diagnosis and treatment of postmenopausal osteoporosis, including the latest guidelines regarding initial choice of agents, as well as duration and sequential use of drugs.


1 CME CREDIT

Type 2 diabetes mellitus (T2DM) is a multi-factorial disease, and its prevalence continues to rise. Lifestyle changes remain a key component of the interventions that require patient participation to initiate and sustain. Additionally, several pharmacological options are available to address the various pathophysiological factors involved in T2DM. Some of these agents have demonstrated cardiovascular benefit, and the renoprotective effect of certain medications has also been investigated with promising results. This knowledge helps PCPs to use appropriate pharmacological agents to individualize treatment plans while following the principles of patient centered care.


0.5 CME CREDIT

When should you recommend Vitamin D to your patients? Based on the latest evidence, which conditions does Vitamin D supplementation help and which does it hinder? Tune in as Dr. Frank Domino sheds some much-needed light on a topic that continues to perplex patients and clinicians alike.


1 CME CREDIT

Throughout this 60-minute session, we will discuss a number of cases where correct interpretation of the clinical presentation and thyroid function tests leads to the correct diagnosis and treatment.


Senior female patient enjoying a run outside
1 CME CREDIT

What do primary care providers need to know about women's health? Join expert faculty as they review important questions they get asked about osteoporosis, and breast cancer care and screening!


0.5 CME CREDIT

Get your questions answered by expert faculty in Endocrinology. You ask: we listen. You will learn practical solutions to common clinical challenges and tips to apply the latest knowledge in practice. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on February 8, 2020 and they are subject to change as new information is published.


man checking his blood by poking his finger
0.5 CME CREDIT

The Role of GIP and GLP-1 in the Pathophysiology of T2DM and Why it Matters (Module 2)

An Interactive Learning Experience From ArcheMedX This course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com

0.50 CME/MOC
0.42 AANP | 0.42 Pharmacology


female stepping on scale
0.5 CME CREDIT

Addressing “Diabesity”: Weight Loss as a Key Therapeutic Goal in the Management of T2DM (Module 1)

An Interactive Learning Experience From ArcheMedX This course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com

0.50 CME/MOC
0.40 AANP | 0.04 Pharmacology


0.5 CME CREDIT

The Case of a 78-Year-Old Woman With Osteoporosis

An Interactive Case ExperienceIn partnership with National Osteoporosis Foundation

0.50 CME/MOC
0.50 AANP | 0.13 Pharmacology

Time to meet your next patient! In this interactive activity, you will be guided through the case of a patient presenting with history of low-trauma fracture via a series of questions and complementary learning opportunities. Questions will test your strengths and weaknesses around diagnosis and management of osteoporosis and people at high risk of fractures, with some questions and feedback tailored directly to your choices. After each question, you will be presented with learning moments designed to help increase your confidence managing patients with osteoporosis.


1 CME CREDIT

Current Issues in Obesity: Stigma, Science, and Solutions

1.00 CME/MOC
1.00 AANP | 0.25 Pharmacology

Obesity is a serious chronic illness that requires long-term management; however, it is also drastically underdiagnosed and undertreated. Arm yourself with a concrete understanding of the physiologic factors that contribute to obesity so that you can effectively manage this disease and prevent comorbid conditions. Hear strategies for developing personalized treatment plans based on current and emerging pharmacotherapies. Most importantly, identify biases that may be hindering your care of patients with obesity.


Physician talking with patient, writing down notes
0.5 CME CREDIT

A Brief Review of Pharmacologic Options for Obesity Management

An Interactive Learning Experience from ArcheMedX This course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com

0.50 CME/MOC
0.50 AANP | 0.50 Pharmacology

Take part in this interactive video-based activity that has been engineered to support your learning! Join obesity medicine experts as they discuss pharmacologic options are approved for long-term treatment of obesity. Learn through a combination of video, questions, pop-up teaching points, and downloadable resources. Faculty will describe the indications for anti-obesity medications and review guidelines for appropriate use of these medications, so you can feel comfortable incorporating these options into your practice. With this activity, you will have access to a resource library that includes slides, abstracts, and practice tools selected by the faculty, and which can be downloaded for future reference.